Request Discount

Multiple Sclerosis Market (Treatment Modality - injectable Agents, and Oral Agents; Application - Hospital, and Research): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : September, 2019

  • Rep Id : HC0677

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Multiple Sclerosis Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Multiple Sclerosis Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Multiple Sclerosis Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on multiple sclerosis market provides an in-depth analysis of segments and sub-segments in the global as well as regional multiple sclerosis market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional multiple sclerosis market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global multiple sclerosis market. According to the report, the global multiple sclerosis market is projected to grow at a healthy CAGR over the forecast period of 2019-2025.

 

Market Insight

Multiple Sclerosis is an inflammatory medical condition characterized by neural demyelination which results in physical and cognitive disability. Companies operating in multiple sclerosis market are adopting strategies such as a merger, acquisition, and new product launches that maximize the market share. In 2016, Teva Industries acquired Actavis Generics. The acquisition enhances the research and development and complementary skills of both companies.

 

The increasing research and development activities in pharmaceutical companies drive the growth of multiple sclerosis market. The increasing number of cases of multiple sclerosis market contributes to the growth of the multiple sclerosis market. As per recent findings from the National Multiple Sclerosis Society, around 2.3 million people globally are suffering from multiple sclerosis. The advancement in technology in the field of multiple sclerosis management fuels the growth of multiple sclerosis market. The increasing government initiatives for reimbursement propel the growth of multiple sclerosis market. On the other side, the unaffordable cost of drugs and the side effects of therapeutics in the treatment of multiple sclerosis hinder the growth of multiple sclerosis market. Moreover, new innovative product launches and different therapies with minimum side effects create novel opportunities for the growth of multiple sclerosis market.

 

On the basis of geography, the global multiple sclerosis market is divided into North America, Asia-Pacific, Europe, and the Rest of the World. North America is anticipated to have a premium share in the global multiple sclerosis market. The growing number of patients suffering from multiple sclerosis in the U.S. contributes to the growth of the multiple sclerosis market in North America. According to findings from the National Multiple Sclerosis Society, around 1 million people in the U.S. are suffering from multiple sclerosis. The Asia-Pacific region is expected to grow in the global multiple sclerosis market with a healthy CAGR over the forecast period. The increasing demand for affordable and effective treatment on multiple sclerosis in the Asia-Pacific region fuels new product launches in the region stimulating the growth of the Asia-Pacific multiple sclerosis market. Europe is also showing growth in the global multiple sclerosis market.


Global Multiple Sclerosis Market

 

Segment Covered

The report on the global multiple sclerosis market covers segments such as treatment modality and application. On the basis of treatment modality, the sub-markets include injectable agents, and oral agents. On the basis of application, the sub-markets include hospital, and research.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Merck & Co. Inc., AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi Aventis, Biogen Idec, F. Hoffmann-La Roche AG, Synthetic Biologics, Inc., and other companies.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of multiple sclerosis market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount